On March 25, 2025, an important informational meeting was held at Pamukkale University Hospital. Organized to raise awareness about Qiagen’s advanced technology product, the Quantiferon TB Gold Plus test, the event brought together numerous specialist physicians and healthcare professionals from various departments.
Representatives from several branches—primarily Adult and Pediatric Infectious Diseases, Dermatology, and Rheumatology—participated in the event. The presentation covered the clinical use of the Quantiferon test, its scientific foundation, application advantages, and result interpretation processes in detail.
The Quantiferon TB Gold Plus test offers a more reliable solution compared to classical methods by providing high specificity and sensitivity in the diagnosis of latent tuberculosis infection.
The main goal of the event was to encourage the more effective use of the test in clinical practice and to build shared awareness among healthcare professionals regarding diagnostic processes.
As Labgen, we will continue to strengthen our collaborations in the healthcare sector and contribute to diagnostic processes with innovative solutions.
